BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 2005;58:26-31. [PMID: 15623478 DOI: 10.1136/jcp.2004.019315] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Sambyal V, Kaur S, Manjari M, Uppal MS, Singh NR, Sudan M, Guleria K. Linkage disequilibrium and haplotypes of five TP53 polymorphisms in oesophageal cancer patients. J Genet 2020;99. [DOI: 10.1007/s12041-020-01224-8] [Reference Citation Analysis]
2 Voropaeva EN, Cherdyntseva NV, Voevoda MI, Pospelova TI, Maximov VN, Orlov YL, Ageeva TA. Triple Haplotypes of the TP53 Gene in Patients with Diffuse Small B-Cell Lymphoma. Russ J Genet 2019;55:1564-8. [DOI: 10.1134/s1022795419120123] [Reference Citation Analysis]
3 Chen M, Li L, Zheng PS. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1. Cancer Sci 2019;110:2794-805. [PMID: 31336010 DOI: 10.1111/cas.14140] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
4 Sontakke BR, Ambulkar PS, Talhar S, Shivkumar PV, Bharambe MS, Pal A. Molecular Genetic Study to Detect Prevalence of High-risk Human Papilloma Virus Strains (type 16 and 18) in Cervical Lesions and Asymptomatic Healthy Subjects of Rural Central India. J Cytol 2019;36:32-7. [PMID: 30745737 DOI: 10.4103/JOC.JOC_10_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Sengupta D, Guha U, Mitra S, Ghosh S, Bhattacharjee S, Sengupta M. Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1 as an Important Associated Locus. Asian Pac J Cancer Prev 2018;19:2071-81. [PMID: 30139066 DOI: 10.22034/APJCP.2018.19.8.2071] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
6 Cui N, Yang WT, Zheng PS. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression. Oncotarget 2016;7:26152-67. [PMID: 27036045 DOI: 10.18632/oncotarget.8434] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
7 Bansal A, Das P, Kannan S, Mahantshetty U, Mulherkar R. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India. Indian J Med Res 2016;144:359-65. [PMID: 28139534 DOI: 10.4103/0971-5916.198685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Nagam SL, Katta S, Prasad VV. Gender specific association of TP53 polymorphisms (EX4 215G>C Arg72Pro, IVS3+40-41ins16, and IVS6+62G>A), with risk of oral cancer subtypes and overall survival of the patients. Mol Carcinog 2017;56:895-912. [PMID: 27532290 DOI: 10.1002/mc.22543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza RC, Jain SK, Khurana N, Ray PC, Saxena A. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clin Transl Oncol 2016;18:728-34. [PMID: 26553387 DOI: 10.1007/s12094-015-1425-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ndiaye R, Dem A, Mbaye PM, Guèye PM, Diop G, Diop PA, Faye O. [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal]. Bull Cancer 2014;101:789-94. [PMID: 25025520 DOI: 10.1684/bdc.2014.1911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 Assoumou SZ, Boumba AL, Ndjoyi-Mbiguino A, Khattabi A, Ennaji MM. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women. Med Oncol 2015;32:281. [PMID: 25502079 DOI: 10.1007/s12032-014-0281-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
12 Voropaeva EN, Voevoda MI, Pospelova TI, Maksimov VN. Linkage disequilibrium and haplotypes of the rs1042522, rs1625895, and rs1787862 markers of TP53 in patients with diffuse large B-cell lymphoma. Mol Biol 2014;48:664-70. [DOI: 10.1134/s0026893314050173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Laprano TD, Lemos EH, Cunha LM, Júnior JE, de SousaTeles RA, Rabenhorst SH. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk. Tumour Biol 2014;35:7435-40. [PMID: 24782034 DOI: 10.1007/s13277-014-1988-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Martin CM, Astbury K, O’leary JJ. Molecular profiling of cervical neoplasia. Expert Review of Molecular Diagnostics 2014;6:217-29. [DOI: 10.1586/14737159.6.2.217] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
15 Voropaeva EN, Voevoda MI, Pospelova TI, Maksimov VN. Intronic polymorphisms of antionkogene TP53 in patients with indolent variants of non-Hodgkin lymphomas. Adv Gerontol 2014;4:42-45. [DOI: 10.1134/s2079057014010135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA, Khussainova EM. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 2013;4:70. [PMID: 23675381 DOI: 10.3389/fgene.2013.00070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
17 Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, Bharadwaj M. Association of MDM2 and p53 Polymorphisms with the Advancement of Cervical Carcinoma. DNA and Cell Biology 2013;32:19-27. [DOI: 10.1089/dna.2012.1718] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
18 Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44. [PMID: 22345983 DOI: 10.4103/0971-6866.92087] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
19 Naccarati A, Polakova V, Pardini B, Vodickova L, Hemminki K, Kumar R, Vodicka P. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 2012;27:211-8. [PMID: 22294769 DOI: 10.1093/mutage/ger067] [Cited by in Crossref: 66] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
20 Umar M, Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. Mol Biol Rep. 2012;39:1153-1162. [PMID: 21573788 DOI: 10.1007/s11033-011-0844-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
21 Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y, Phukan R, Mahanta J, Kataki AC, Kapur S, Saxena S. Investigation on the Role of p53 Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India. DNA and Cell Biology 2011;30:163-71. [DOI: 10.1089/dna.2010.1119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
22 Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp Mol Pathol 2011;90:167-72. [PMID: 21115003 DOI: 10.1016/j.yexmp.2010.11.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
23 Jiang P, Liu J, Li W, Zeng X, Tang J. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Acta Biochim Biophys Sin (Shanghai) 2010;42:671-6. [PMID: 20732856 DOI: 10.1093/abbs/gmq069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
24 Bellini I, Pitto L, Marini MG, Porcu L, Moi P, Garritano S, Boldrini L, Rainaldi G, Fontanini G, Chiarugi M, Barale R, Gemignani F, Landi S. DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region. Hum Mutat 2010;31:456-65. [PMID: 20127977 DOI: 10.1002/humu.21214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
25 Jiang P, Liu J, Zeng X, Li W, Tang J. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer Genetics and Cytogenetics 2010;197:174-8. [DOI: 10.1016/j.cancergencyto.2009.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
26 Hu Z, Li X, Qu X, He Y, Ring BZ, Song E, Su L. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis. 2010;31:643-647. [PMID: 20089604 DOI: 10.1093/carcin/bgq018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
27 El khair MM, Ennaji MM, El kebbaj R, Mhand RA, Attaleb M, El Mzibri M. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Med Oncol 2010;27:861-6. [DOI: 10.1007/s12032-009-9297-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
28 Hrstka R, Coates PJ, Vojtesek B. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. J Cell Mol Med. 2009;13:440-453. [PMID: 19379143 DOI: 10.1111/j.1582-4934.2008.00634.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
29 Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das B, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai M, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu M, Yamashita T, Zehbe I, Blettner M. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. The Lancet Oncology 2009;10:772-84. [DOI: 10.1016/s1470-2045(09)70187-1] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 8.7] [Reference Citation Analysis]
30 Pospelova TI, Voyevoda MI, Voropayeva YN, Belyavskaya VA, Kovynev IB, Berezina OV. Value of constitutional polymorphisms gene <i>р53</i> at patients with non-Hodgkin’s lymphomas. Bûll sib med 2008;7:56-63. [DOI: 10.20538/1682-0363-2008-0-56-63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Lange CE, Tobler K, Favrot C, Müller M, Nöthling JO, Ackermann M. Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay. Clin Vaccine Immunol 2009;16:66-72. [PMID: 19038784 DOI: 10.1128/CVI.00346-08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pangilinan F, Geiler K, Dolle J, Troendle J, Swanson DA, Molloy AM, Sutton M, Conley M, Kirke PN, Scott JM, Mills JL, Brody LC. Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. Am J Med Genet A 2008;146A:2617-25. [PMID: 18798306 DOI: 10.1002/ajmg.a.32504] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
33 Zheng X, Yang A, Pan X, Zheng L, Wang X, Zhou Q, Li X, Yan L, Zhang B, Li H, Jiang J. Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. European Journal of Cancer Prevention 2008;17:460-6. [DOI: 10.1097/cej.0b013e3282f75f3e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
34 Martin CM, Kehoe L, Spillane CO, O'Leary JJ. Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers. Mol Diagn Ther 2007;11:277-90. [PMID: 17963416 DOI: 10.1007/BF03256249] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
35 Oliveira S, Sousa H, Santos A, Pinto D, Pinto-correia A, Fontoura D, Moutinho J, Medeiros R. The p53 R72P polymorphism does not influence cervical cancer development in a portuguese population: A study in exfoliated cervical cells. J Med Virol 2008;80:424-9. [DOI: 10.1002/jmv.21103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
36 Verma M, Seminara D, Arena FJ, John C, Iwamoto K, Hartmuller V. Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification. Mol Diagn Ther 2006;10:1-15. [PMID: 16646573 DOI: 10.1007/BF03256438] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
37 Buyru N, Altinisik J, Demokan S, Dalay N. p53 genotypes and haplotypes associated with risk of breast cancer. Cancer Detection and Prevention 2007;31:207-13. [DOI: 10.1016/j.cdp.2007.04.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
38 Mitra S, Banerjee S, Misra C, Singh RK, Roy A, Sengupta A, Panda CK, Roychoudhury S. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol. 2007;60:1040-1047. [PMID: 17079356 DOI: 10.1136/jcp.2005.034835] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
39 De Chaudhuri S, Mahata J, Das JK, Mukherjee A, Ghosh P, Sau TJ, Mondal L, Basu S, Giri AK, Roychoudhury S. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2006;601:102-12. [PMID: 16930632 DOI: 10.1016/j.mrfmmm.2006.06.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
40 Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602-11. [DOI: 10.1038/sj.onc.1209367] [Cited by in Crossref: 158] [Cited by in F6Publishing: 141] [Article Influence: 9.9] [Reference Citation Analysis]
41 Koushik A, Ghosh A, Duarte-franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention 2005;29:307-16. [DOI: 10.1016/j.cdp.2005.06.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]